Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide injection vs NovoNorm liraglutide plus metformin in type 2 diabetes
CTR20190444Phase 3Completed
- Sponsor
- Jiuyuan Gene Engineering
- Start
- Mar 2019
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of liraglutide in type 2 diabetes mellitus (T2DM), sponsored by Jiuyuan Gene Engineering. Started Mar 2019; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20190444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190444.